Effects of Dapagliflozin on Patient Reported Treatment Satisfaction in Patients with Type 2 Diabetes Mellitus-Results from Two Double-Blind Trials

被引：0
|
作者：
Medin, Jennie
Grandy, Susan
Rohwedder, Katja
Hruba, Veronica
Sugg, Jennifer
Langkilde, Anna Maria
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2269-PO
引用
收藏
页码：A604 / A604
页数：1
相关论文
共 50 条
  • [41] Fixed-dose Combination of Dapagliflozin and Linagliptin in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomized Double-blind Multicenter Trial
    Kumthekar, Prashant
    Upadhyay, Mihir R.
    Tamma, Rajasekhara Reddy
    Kranti, Vijay
    Bhattacharya, Raja
    Sharma, Prabhat Kumar
    Barge, Vijaykumar Bhagwan
    Revankar, Santosh
    Ghatge, Shweta
    JOURNAL OF DIABETOLOGY, 2025, 16 (01)
  • [42] Relationship between improved patient satisfaction and improved glycemic control in patients with type 1 and type 2 diabetes mellitus treated with inhaled insulin: Pooled results from two multicenter randomized controlled trials
    Cappelleri, JC
    Gerber, RA
    Rosenstock, J
    Nadkarni, S
    Petrie, CD
    Kourides, IA
    DIABETES, 2001, 50 : A108 - A108
  • [43] Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study
    Cho, Yun Kyung
    Kim, Kyung-Soo
    Lee, Byung-Wan
    Hong, Jun Hwa
    Yu, Jae Myung
    Lim, Soo
    Kim, Ye An
    Lee, Chang Beom
    Kim, Sang Soo
    Kwak, Soo Heon
    Lee, Woo Je
    CLINICAL THERAPEUTICS, 2024, 46 (09) : 662 - 669
  • [44] Clinical Efficacy, Safety, and Tolerability of Single-Pill Combination of Dapagliflozin and Linagliptin in Uncontrolled Indian Type 2 Diabetes Mellitus Patients-A Randomized Double-Blind Study
    Ahmad, Jamal
    Ghosh, Sayan
    Kumthekar, Prashant P.
    Upadhyay, Mihir R.
    Sonawane, Kunal S.
    Khalse, Maneesha
    Patel, Kamlesh
    DIABETES, 2024, 73
  • [45] Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus - A randomized, double-blind, placebo-controlled trial
    Maggs, DG
    Buchanan, TA
    Burant, CF
    Cline, G
    Gumbiner, B
    Hsueh, WA
    Inzucchi, S
    Kelley, D
    Nolan, J
    Olefsky, JM
    Polonsky, KS
    Silver, D
    Valiquett, TR
    Shulman, GI
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) : 176 - 185
  • [46] The Impact of Diabetes Education by Clinical Pharmacist on Quality of Life and Treatment Satisfaction of Sudanese Individuals With Type II Diabetes Mellitus: Randomized, Double-Blind, Controlled Trial
    Badi, Safaa
    Suliman, Sara Zainelabdein
    Almahdi, Rayan
    Aldomah, Mohammed A.
    Ahmed, Mohamed H.
    Elkheir, Habab Khalid
    Ibrahim, Mohamed Izham Mohamed
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15
  • [47] A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus
    Huang, Lei
    Cao, Bei
    Geng, Yan
    Zhou, Xiaoli
    Yang, Yuanxun
    Ma, Tingting
    Lin, Hui
    Huang, Zhijiang
    Zhuo, Lang
    Li, Juan
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [48] Ficus carica Leaves Decoction on Glycemic Factors of Patients With Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial
    Mazhin, Sadegh Ahmadi
    Zaker, Marziyeh Asadi
    Shahbazian, Hajie Bibi
    Azemi, Mohammad Ebrahim
    Madanchi, Nima
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (01)
  • [49] A Randomized, Double-Blind, Placebo-Controlled Study for Diacerein in Patients with Inadequately Controlled Type 2 Diabetes Mellitus
    Pei, Dee
    Huang, Chien-Ning
    Chen, Ching-Chu
    Hsia, Te-Lin
    Lu, Wei-Shu
    Lin, Yi-Yin
    Ku, M. Sherry
    DIABETES, 2011, 60 : A84 - A85
  • [50] Efficacy and safety of glucokinase activators for type 2 diabetes mellitus therapy: a meta-analysis of double-blind randomized controlled trials
    Qu, Y.
    Wang, K.
    Lin, S.
    Cao, L.
    Xu, Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (02) : 914 - 922
12345